Phase I Trial of Carboplatin, Paclitaxel, Etoposide, and Cyclophosphamide with Granulocyte Colony Stimulating Factor as First-Line Therapy for Patients with Advanced Epithelial Ovarian Cancer

By Tung N.   Berkowitz R.   Matulonis U.   Quartulli M.   Seiden M.   Kim Y.   Niloff J.   Cannistra S.A.  

Gynecologic Oncology, Vol. 77, Iss. 2, 2000-05 ,pp. : 271-277

Elsevier

Access to resources Recommend Favorite

First-line chemotherapy with epidoxorubicin, paclitaxel, and carboplatin for the treatment of advanced epithelial ovarian cancer patients

By Romanini A.   Tanganelli L.   Carnino F.   Fanucchi A.   Lionetto R.   Pastorino S.   Cosio S.   Gadducci A.   Conte P.F.  

Gynecologic Oncology, Vol. 89, Iss. 3, 2003-06 ,pp. : 354-359

Elsevier

Access to resources Recommend Favorite

First-Line Chemotherapy with Paclitaxel and Platinum for Advanced and Recurrent Cancer of the Cervix-A Phase II Study

By Piver M.S.   Ghamande S.A.   Eltabbakh G.H.   O'Neill-Coppola C.  

Gynecologic Oncology, Vol. 75, Iss. 3, 1999-12 ,pp. : 334-337

Elsevier

Access to resources Recommend Favorite

Phase I Study of Alternating Doublets of Topotecan/Carboplatin and Paclitaxel/Carboplatin in Patients with Newly Diagnosed, Advanced Ovarian Cancer

By Gordon A.N.   Hancock K.C.   Matthews C.M.   Messing M.   Stringer C.A.   Doherty M.G.   Teneriello M.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 129-135

Elsevier

Access to resources Recommend Favorite

Weekly one-hour paclitaxel as first-line chemotherapy for metastatic breast cancer

By Wist Erik Andreas   Sommer Hilde Heen   Østenstad Bjørn   Risberg Terje   Fjæstad Knut  

Acta Oncologica, Vol. 43, Iss. 1, 2004-03 ,pp. : 11-14

Informa Healthcare

Access to resources Recommend Favorite